Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.900
+0.3406.12%
Volume:7.94M
Turnover:45.87M
Market Cap:9.42B
PE:-18.74
High:5.950
Open:5.560
Low:5.545
Close:5.560
52wk High:10.410
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.23
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.23
PE(LYR):-18.74
PS:18.93

Loading ...

CStone Pharma-B (02616) Jumps Nearly 7% as ESMO Data Update Nears and Executive's Continued Share Purchases Signal Confidence in Growth

Stock News
·
Sep 29

CStone Pharma-B Interim 2026: Revenue Jumps 315%, Net Loss Narrows on Pralsetinib Momentum

Bulletin Express
·
Sep 28

CStone Pharma CEO Buys HK$2.7 Million of Shares

MT Newswires Live
·
Sep 24

CStone Pharma-B (02616) Announces CEO and Executive Director Yang Jianxin's Purchase of 496,000 Shares

Stock News
·
Sep 24

CStone Pharmaceuticals - CEO Purchases 496,000 Shares for over Hk$2.7 Mln from Sept 17-22, 2026

THOMSON REUTERS
·
Sep 24

HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%

Tiger Newspress
·
Sep 23

Executive Director and CEO Dr. Yang Jianxin Raises Stake in CStone Pharmaceuticals with Share Purchase

Stock News
·
Sep 17

CSTONE PHARMA-B: Jianxin Yang Acquires Shares, Long Position Rises to 5.29%

HK Disclosure
·
Sep 17

Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones

Stock News
·
Sep 08

CStone Pharmaceuticals Joins Stock Connect Southbound Trading

MT Newswires Live
·
Sep 07

CStone Pharmaceuticals Included in Southbound Stock Connect, Targeting Greater Liquidity and Global Trial Progress

Bulletin Express
·
Sep 07

CStone Pharma Shares Added to Southbound Stock Connect Eligible List

Reuters
·
Sep 07

CStone Pharmaceuticals Posts Marginal Share Increase in August 2026 Monthly Return

Bulletin Express
·
Sep 04

Is CStone Pharmaceuticals (SEHK:2616) Fully Valued On Interim Results And CS2009 Progress?

Simply Wall St.
·
Sep 03

CSTONE PHARMA-B (02616) climbs over 4% in early trade; sales surge after listing in state medical insurance

Stock News
·
Sep 02

CStone Plans First Wave of Global Phase III Trials for Cs2009 by End-2026

Reuters
·
Aug 31

CStone Says Pralsetinib Sales Volume Jumps Nearly 500% After China NRDL Listing

Reuters
·
Aug 31

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 31

China's Zhaoke Ophthalmology H1 Revenue Rises

Reuters
·
Aug 28

CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy

Simply Wall St.
·
Aug 28